Josh Lehrer
Chief Executive Officer @Marea Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer @Marea Therapeutics
San Francisco, CA, US
EDUCATION
University of Cambridge
M.Phil., Biological Sciences
Harvard University
A.B., Biochemical Sciences
University of California, San Francisco
Doctor of Medicine (M.D.), Internal Medicine Resident
Stanford University Graduate School of Business
Certificate of Entrepreneurship, Summer Institute for Entrepreneurship
Stanford University
Fellow, Cardiology
University of California, San Francisco - School of Medicine
MD, Medicine
SKILLS
ABOUT JOSH LEHRER
I’m a biotech CEO and physician-scientist with a passion for building great teams to deliver transformative therapies. Over the past 15+ years, I’ve led companies from formation through IPO, clinical proof of concept, and successful M&A, with experience across rare disease, cardiovascular/metabolic, endocrine and gene editing programs.Currently, I serve as CEO of Marea Therapeutics, where we’re advancing a pipeline of cardio-endocrine therapies. Previously, I was founding CEO of Graphite Bio, which I built from an academic idea into a public company. Before that, I was CMO at Global Blood Therapeutics, Oxbryta from development through launch and contributed to GBT’s acquisition by Pfizer.My background spans clinical medicine, R&D, regulatory engagement, and corporate strategy. I’ve raised over $1.7B in capital, built high-performing leadership teams, and presented at global investor, medical, and regulatory forums.Originally trained in cardiology and internal medicine at UCSF and Stanford, I’ve also done research at Harvard, Cambridge, UCSF, and Genentech, with publications in The Lancet, NEJM, and Science.I love leading mission-driven teams to innovate at the intersection of science, medicine, and corporate strategy.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.